DVOT Nipah Virus Antigen Rapid Test kit

The Nipah Virus Antigen Rapid Test Kit is a lateral flow–based immunoassay designed for the qualitative identification of Nipah virus antigens in human capillary whole blood collected via finger-prick. This test is intended for use by qualified healthcare personnel to support the preliminary screening of individuals suspected of Nipah virus infection. Test outcomes must be evaluated alongside clinical findings and epidemiological data. Reactive results should be verified using confirmatory laboratory methods. For professional use only.

What is nipah virus?

Nipah virus (NiV) is a zoonotic virus—meaning it spreads from animals to humans—that belongs to the Paramyxoviridae family. Its natural reservoir is fruit bats (flying foxes), and humans can become infected through:

• Direct contact with infected bats or animals (such as pigs)
• Consumption of contaminated food (e.g., raw date palm sap)
• Human-to-human transmission, especially through close contact with bodily fluids

Disease and severity

Nipah virus infection can cause severe illness, most commonly:

• Acute encephalitis (brain inflammation)
• Serious respiratory disease

Clinical observations show an extremely high fatality rate of around 75%, indicating a very poor prognosis for many patients. Survivors may also experience long-term neurological complications.

Public health impact

The high mortality rate makes the Nipah virus particularly dangerous and difficult to control:

• It places intense pressure on healthcare systems, requiring intensive care units and highly trained medical staff
• The severity and fatal outcomes can trigger public fear and social panic
• Its multiple transmission routes (animal-to-human and human-to-human) complicate efforts to break the transmission chain quickly

Because of these factors, the Nipah virus is considered a major global public health threat and is listed by the WHO as a priority pathogen requiring urgent research and preparedness.

Nipah Virus Antigen Rapid Test Key Features

• High Accuracy (>98%): Clinically validated with over 98% accuracy for reliable Nipah virus antigen detection.
• Fingertip Blood Sampling: Uses fingertip blood samples, providing higher accuracy compared to saliva or urine testing.
• Rapid Results: Delivers clear test results within 15 minutes, enabling fast screening and decision-making.
• Easy to Use: Simple testing procedure with minimal steps, suitable for both professional and point-of-care use.